Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis.
Newly diagnosed multiple sclerosis in state of Qatar.
Clinical assessment of noninvasive intracranial pressure absolute value measurement method.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Do neutralising antibodies against exogenous interferon-beta inhibit endogenous signalling pathways?
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Breastfeeding is associated with lower risk for multiple sclerosis.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Multiple sclerosis: summary of NICE guidance.
Novartis acquires all remaining rights to GSK's Ofatumumab to develop treatments for MS and other autoimmune indications
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Clinical spectrum of CNS aquaporin-4 autoimmunity.
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Four Square Step Test in ambulant persons with multiple sclerosis: validity, reliability, and responsiveness.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
MRI characteristics of familial and sporadic multiple sclerosis patients.
Can smoking aggravate my multiple sclerosis symptoms?
Impact of diagnosis and early treatment on the course of multiple sclerosis.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »